Page last updated: 2024-10-27

flecainide and Cerebrovascular Disorders

flecainide has been researched along with Cerebrovascular Disorders in 3 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Bortoli, A1
Shi, LB1
Ohm, OJ1
Hoff, PI1
Schuster, P1
Solheim, E1
Chen, J1
Reeb, T1
de Chillou, C1
Sadoul, N1
Lacour, JC1
Ducrocq, X1
Debouverie, M1
Weber, M1
Aliot, E1
Guarnieri, T1
Tomaselli, G1
Griffith, LS1
Brinker, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter[NCT03401099]113 participants (Actual)Interventional2018-08-17Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for flecainide and Cerebrovascular Disorders

ArticleYear
Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter.
    Scandinavian cardiovascular journal : SCJ, 2017, Volume: 51, Issue:3

    Topics: Aged; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Catheter Ablation

2017
[Atrial electrophysiological study of unexplained ischemic cerebrovascular disorders].
    Archives des maladies du coeur et des vaisseaux, 1995, Volume: 88, Issue:12

    Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Cere

1995
The interaction of antiarrhythmic drugs and the energy for cardioversion of chronic atrial fibrillation.
    Pacing and clinical electrophysiology : PACE, 1991, Volume: 14, Issue:6

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cerebrovascular Disorders; Chr

1991